Allergy, Immunology, and ENT

Latest News

FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years

May 13th 2024

The federal agency has accepted the sBLA for Priority Review designation, with a target action date of September 15, 2024.

Higher BMI, obesity probability not associated with early peanut introduction | Image Credit: © Stepan Popov - © Stepan Popov - stock.adobe.com.
Higher BMI, obesity probability not associated with early peanut introduction

May 3rd 2024

FDA approves mavorixafor as first drug for WHIM syndrome | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves mavorixafor as first drug for WHIM syndrome

April 29th 2024

Image Credit: © Elena Medoks - © Elena Medoks - stock.adobe.com.
Viaskin milk patch demonstrates mixed results, phase 1/2 data shows

March 1st 2024

Robert Wood, MD | Image Credit: Hopkinsmedicine.org
Experts share their thoughts on the omalizumab OUtMATCH phase 3 data

February 29th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.